Tag: #GraftSurvival

Introduction Renal transplantation remains the gold standard for treating end-stage renal disease (ESRD), offering superior survival benefits compared to dialysis. However, patients with a positive crossmatch (PXM) face significant challenges due to donor-specific antibodies (DSA), increasing the risk of rejection. Recent advancements in desensitization protocols have enabled successful kidney transplants in sensitized patients. A study…